Treatment approaches for alcohol use disorder with metabolic dysfunction

Area of Science:

• Hepatology
• Psychiatry
• Addiction Medicine

Background:

• Alcohol use disorder (AUD) and metabolic dysfunction (obesity, diabetes, etc.) independently increase morbidity and mortality.
• Their combination has synergistic effects on liver disease progression and overall mortality.
• Existing treatments for AUD are insufficient for individuals with co-occurring metabolic issues.

Purpose of the Study:

• To synthesize knowledge on the shared pathophysiology of AUD and metabolic dysfunction.
• To identify gaps in current treatment paradigms for this comorbid population.
• To explore how emerging treatments for liver diseases inform clinical strategies.

Main Methods:

• Literature review synthesizing data from hepatology, psychiatry, and addiction medicine.
• Analysis of mortality trends associated with co-occurring AUD and metabolic dysfunction.
• Evaluation of emerging research and treatments for MASLD, MetALD, and ALD.

Main Results:

• AUD and metabolic dysfunction share complex pathophysiological links.
• This comorbid population faces unique clinical challenges and elevated mortality risks.
• Current AUD treatments lack integration with metabolic health considerations.

Conclusions:

• There is a critical need for unified frameworks to treat individuals with co-occurring AUD and metabolic dysfunction.
• Tailored therapeutic strategies addressing both conditions are essential.
• Further research is needed to bridge the gap between AUD and metabolic disorder treatments.